The Severe Chronic Neutropenia International Registry (the Registry) opened in 1994 to study the long-term safety and efficacy of granulocyte-colony stimulating factor (G-CSF) treatment for patients with congenital, cyclic and idiopathic neutropenia. The Registry initially evaluated hematological parameters, growth and development, consequence of pregnancy, and other important clinical events. The Registry is now an international research organization based at the University of Washington. In this grant, we request funding to continue the work of the Registry. In brief, the specific aims are: (1) To expand the longitudinal clinical database on patients with severe chronic neutropenia, (2) To expand a bank of biological materials to support genetic and molecular research and study the evolution of patients at risk to develop myelodysplasia and leukemia, (3) To serve as a resource to support clinical trials to improve therapy, (4) To serve as a educational resource for patients, families, physicians and other care providers, (5) To cooperate with researchers studying the other hematopoietic failure disorders. All of these efforts are directed toward improving understanding of the care of patients with severe chronic neutropenia.

Public Health Relevance

The Registry benefits patients, their families and the physicians who treat them by providing the most up to date information to them on the natural history of SCN and its treatment options, leading to improved medical care. It is also used to further research to determine the causes of neutropenia.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Resource-Related Research Projects (R24)
Project #
3R24AI049393-10S1
Application #
8914819
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Johnson, David R
Project Start
2001-01-01
Project End
2015-08-31
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
10
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of Washington
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Seattle
State
WA
Country
United States
Zip Code
98195
Dale, David C (2018) Editorial: myeloid biology issue 2018. Curr Opin Hematol 25:1-2
Dale, David C; Crawford, Jeffrey; Klippel, Zandra et al. (2018) A systematic literature review of the efficacy, effectiveness, and safety of filgrastim. Support Care Cancer 26:7-20
Xia, Jun; Miller, Christopher A; Baty, Jack et al. (2018) Somatic mutations and clonal hematopoiesis in congenital neutropenia. Blood 131:408-416
Makaryan, Vahagn; Kelley, Merideth L; Fletcher, Breanna et al. (2017) Elastase inhibitors as potential therapies for ELANE-associated neutropenia. J Leukoc Biol 102:1143-1151
Skokowa, Julia; Dale, David C; Touw, Ivo P et al. (2017) Severe congenital neutropenias. Nat Rev Dis Primers 3:17032
Dale, David C (2017) How I manage children with neutropenia. Br J Haematol 178:351-363
Dale, David C (2017) Editorial for myeloid biology 2017. Curr Opin Hematol 24:1-2
Dale, David C; Bolyard, AudreyAnna; Marrero, Tracy et al. (2017) Long-Term Effects of G-CSF Therapy in Cyclic Neutropenia. N Engl J Med 377:2290-2292
Dale, David C; Bolyard, Audrey A (2017) An update on the diagnosis and treatment of chronic idiopathic neutropenia. Curr Opin Hematol 24:46-53
Dale, David C (2016) Editorial: The mysteries of the spleen. J Leukoc Biol 100:249-51

Showing the most recent 10 out of 52 publications